GridAI Technologies (GRDX) Other Working Capital Changes (2021 - 2025)
GridAI Technologies' (GRDX) quarterly Other Working Capital Changes came in at -$40548.0 in Q4 2025, up 96.11% on a YoY basis from -$20676.6 in Q4 2024, and down 723.31% quarter-over-quarter from -$4925.0 in Q1 2025.
Analysis
GridAI Technologies (GRDX) Other Working Capital Changes (2021 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has reported Other Working Capital Changes for 5 consecutive years, with -$40548.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 96.11% year-over-year to -$40548.0; the trailing twelve-month figure through Dec 2025 stood at -$45473.0 (up 95.86% YoY), and the FY2025 full-year result was -$45473.0, up 95.86% from the prior year.
- Other Working Capital Changes declined to -$40548.0 in Q4 2025 per GRDX's latest filing, from -$4925.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $32305.0 in Q4 2021 and bottomed at -$1.0 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged -$87599.5 across 5 years, with a median of -$17083.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes sank 5941.92% in 2024, then jumped 96.11% in 2025.
- Over 5 years, Other Working Capital Changes stood at $32305.0 in 2021, then slumped by 147.91% to -$15478.0 in 2022, then slipped by 11.33% to -$17232.0 in 2023, then tumbled by 5941.92% to -$1.0 million in 2024, then surged by 96.11% to -$40548.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$40548.0, -$4925.0, and -$1.0 million for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -40,548.00 |
| Dec 31, 2025 | -40,548.00 |
| Mar 31, 2025 | -4,925.00 |
| Mar 31, 2025 | -4,925.00 |
| Dec 31, 2024 | -1.04 Mn |
| Dec 31, 2024 | -1.04 Mn |
| Sep 30, 2024 | -18,800.00 |
| Sep 30, 2024 | -18,800.00 |
| Jun 30, 2024 | -20,341.00 |
| Jun 30, 2024 | -20,341.00 |
| Mar 31, 2024 | -18,863.00 |
| Mar 31, 2024 | -18,863.00 |
| Dec 31, 2023 | -17,232.00 |
| Dec 31, 2023 | -17,232.00 |
| Sep 30, 2023 | -16,934.00 |
| Sep 30, 2023 | -16,934.00 |
| Jun 30, 2023 | -16,234.00 |
| Jun 30, 2023 | -16,234.00 |
| Mar 31, 2023 | -15,751.00 |
| Mar 31, 2023 | -15,751.00 |